Galantamine as an adjunctive treatment in major depression

Journal of Clinical Psychopharmacology

Volumn 28, Issue 3, 2008, Pages 357-359

  Elgamal, Safa ^a   MacQueen, Glenda ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; CLONAZEPAM; DESIPRAMINE; GABAPENTIN; GALANTAMINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; SERTRALINE; TRAZODONE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CHOLINESTERASE INHIBITOR;

ADD ON THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; HYPERSOMNIA; LETTER; MAJOR DEPRESSION; MALE; MOOD; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; ADULT; AFFECT; AGED; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PERSONALITY TEST;

ADULT; AFFECT; AGED; ANTIDEPRESSIVE AGENTS; CHOLINESTERASE INHIBITORS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GALANTAMINE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY;

EID: 51449094238     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318172756c     Document Type: Letter

References (14)

1. Raskind MA, Peskind ER, Wessel T, et al. Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology. 2000;54:2261-2268.
2. Scott LJ, Goa KL. Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000; 60:1095-1122.
3. Burt T. Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents. Curr Psychiatry Rep. 2000;2: 473-478.
4. Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol. 2004;18: 457-474.
5. Ferguson SM, Brodkin JD, Lloyd GK, et al. Antidepressant-like effects of the subtypeselective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Psychopharmacology (Berl). 2000;152:295-303.
6. Salin-Pascual RJ, Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. Neuroreport. 1998;9:57-60.
7. Semba J, Mataki C, Yamada S, et al. Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biol Psychiatry. 1998;43:389-391.
8. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23: 56-62.
9. Delis DC KJ, Kaplan E, Ober BA. California Verbal Learning Test Manual. San Antonio, TX: Psychological Corporation; 1987.
10. Reitan. Trail Making Test: Manual for administration and Scoring. Tucson, AZ: Reitan Neuropsychology Laboratory; 1992.
11. Ruff RM. What role does depression play on the performance of the Ruff 2 and 7 Selective Attention Test? Percept Mot Skills. 1996;78: 63-66.
12. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: The Psychological Corporation; 1981.
13. Benton AL HK. Multilingual aphasic examination, Manual of Instructions. Iowa City, IA: AJA Associates; 1989.
14. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, UK: NFER- Nelson; 1982.